Tonix Pharmaceuticals Reports Second Quarter 2023 Financial

Tonix Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Highlights

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Massachusetts , United States , Chatham , American , Seth Lederman , Zembrace Symtouch , Gregory Sullivan , Angela Fang , Ben Shannonicr Westwicke , Peter Vozzoicr Westwicke , Antoinette Maassen , Elizabeth Lawson , National Institutes Of Health , Scientists At Tonix Research , Aegis Therapeutics , Upsher Smith Laboratories , National Institute On Drug Abuse , Neurelis Inc , Drug Administration , Tonix Pharmaceuticals , Tonix Pharmaceuticals Holding Corp , Jessica Morristonix Pharmaceuticals , Exchange Commission , Development Center , University Of Washington , Erasmus University Medical Center , Nasdaq , Topline Results , Trials Expected , Fourth Quarters , Topline Results Expected , Fourth Quarter , Enabling Study , Centrally Acting Non Opioid Analgesic , Strategic Acquisition , Two Marketed Acute Migraine Products , Pharmaceuticals Holding , Chief Executive Officer , New Drug Application , Orphan Drug Designation , Chief Medical Officer , Massachusetts General Hospital , Key Product , Data Readouts , Central Nervous System , Pipeline During , Concept Study , Nervous System , Fibromyalgia Type Long , Post Acute Sequelae , Principal Investigator Elizabeth , Principal Investigator Angela , National Institutes , Neurovascular Pharmacology , Cooperative Agreement , National Institute , Drug Abuse , Breakthrough Therapy , Orphan Drug , Pharmaceuticals Holding Corp , Private Securities Litigation Reform Act , Annual Report , Except Share , Per Share Amounts , Months Ended June , Morristonix Pharmaceuticals , Patient Information , Tonix Pharmaceuticals Holding ,